We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hormone Replacement Therapy in Post-Menopause Hormone-Dependent Gynecological Cancer Patients: A Narrative Review.
- Authors
Villa, Paola; Bounous, Valentina Elisabetta; Amar, Inbal Dona; Bernardini, Federica; Giorgi, Margherita; Attianese, Daniela; Ferrero, Annamaria; D'Oria, Marika; Scambia, Giovanni
- Abstract
Background. Advances in the treatment of gynecological cancer have led to improvements in survival but also an increase in menopausal symptoms, especially in young women with premature iatrogenic menopause. Methods. A narrative review was performed to clarify the possibility of prescribing hormone replacement therapy (HRT) after hormone-dependent gynecological cancers (ovarian cancer [OC], cervical adenocarcinoma [AC], and endometrial cancer [EC]). Results. HRT can be prescribed to patients with early-stage, grade I–II OC who experience bothersome menopausal symptoms non-responsive to alternative non-hormone therapy after optimal surgery. Caution should be exercised in administering HRT after serous borderline tumors and endometrioid OC, and HRT is not recommended in low-grade serous OC. HRT is not contraindicated in AC survivors. After surgery for EC, HRT can be prescribed in women with early-stage low-grade EC. There is not enough data to give indications to patients with advanced EC. Conclusions. HRT can be discussed with patients, evaluating the risks and benefits of hormone-dependent gynecological cancer. Counseling should be performed by gynecologic oncologists experienced in the management of these patients.
- Subjects
HORMONE therapy; ENDOMETRIAL surgery; CANCER patients; CLIMACTERIC; POSTMENOPAUSE; PREMATURE menopause; OVARIAN cancer
- Publication
Journal of Clinical Medicine, 2024, Vol 13, Issue 5, p1443
- ISSN
2077-0383
- Publication type
Article
- DOI
10.3390/jcm13051443